Requests that the FDA Investigate Mayo Clinic Promotion and Use of Robotic Nipple-Sparing Mastectomy Using the da Vinci SP Surgical System Outside the Ongoing Investigational Device Exemption; Investigate Intuitive Surgicals Role in this Promotion; Reevaluate Clearance of da Vinci SP Surgical System for Robotic Nipple-Sparing Mastectomy (K252675); Require Post-Market Surveillance/Labeling Changes | Federal Regulations · Congress.wiki